Skip to main content
logo
Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
18.92
-0.04 (-0.21%)
At close: Apr 1, 2026, 4:00 PM EDT
18.63
-0.29 (-1.53%)
Pre-market: Apr 2, 2026, 4:52 AM EDT

Summit Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
14,67013,56113,1671,831897264
Market Cap Growth
0.29%3.00%618.96%104.13%240.18%-32.05%
Enterprise Value
13,97712,86512,7581,7481,066193.63
Last Close Price
18.9217.4917.852.614.252.69
PE Ratio
--12.15-57.58-2.64-10.37-4.01
PS Ratio
----1272.54145.79
PB Ratio
22.2720.5833.8723.577.083.17
P/TBV Ratio
21.4719.8532.9920.826.494.25
P/FCF Ratio
--41.91-92.56-23.82-21.26-3.62
P/OCF Ratio
--41.99-92.65-23.86-21.58-3.63
EV/Sales Ratio
----1511.50107.04
EV/EBITDA Ratio
-11.75-56.47-2.88-15.05-2.31
EV/EBIT Ratio
-11.76-56.45-2.87-14.78-2.25
EV/FCF Ratio
--39.76-89.69-22.74-25.25-2.66
Debt / Equity Ratio
0.030.030.011.334.080.02
Debt / EBITDA Ratio
0.020.02-0.03-0.17-7.32-0.03
Debt / FCF Ratio
-0.06-0.06-0.05-1.38-12.29-0.04
Net Debt / Equity Ratio
-1.05-1.05-1.04-1.031.34-0.83
Net Debt / EBITDA Ratio
-0.63-0.631.790.13-2.400.82
Net Debt / FCF Ratio
2.142.142.851.04-4.030.95
Asset Turnover
-0000.000.02
Quick Ratio
9.779.779.899.179.153.47
Current Ratio
9.879.8710.159.3016.933.80
Return on Equity (ROE)
-206.10%-206.10%-94.90%-601.85%-75.05%-108.89%
Return on Assets (ROA)
184.44%184.44%-70.79%-140.62%-18.54%-79.85%
Return on Invested Capital (ROIC)
-5145.51%-5145.51%3442.99%-408.16%-44.39%-334.27%
Return on Capital Employed (ROCE)
204.18%204.18%-78.42%-150.92%-20.22%-101.18%
Earnings Yield
-7.36%-8.23%-1.74%-37.93%-9.65%-24.91%
FCF Yield
-2.21%-2.39%-1.08%-4.20%-4.70%-27.64%
Buyback Yield / Dilution
-4.06%-4.06%-15.96%-220.50%-46.78%-89.45%
Total Shareholder Return
-4.06%-4.06%-15.96%-220.50%-46.78%-89.45%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q